Louis Chen
Stock Analyst at Cantor Fitzgerald
(n/a)
# 4,874
Out of 4,876 analysts
11
Total ratings
9.09%
Success rate
-56.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $3.76 | - | 8 | Sep 10, 2024 | |
| THTX Theratechnologies | Reiterates: Overweight | $36 | $2.37 | +1,422.20% | 2 | Jul 13, 2023 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $32.58 | +68.82% | 1 | Feb 24, 2022 |
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $3.76
Upside: -
Theratechnologies
Jul 13, 2023
Reiterates: Overweight
Price Target: $36
Current: $2.37
Upside: +1,422.20%
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $32.58
Upside: +68.82%